Read the Latest Edition of The Lens, a new magazine by LSI arrow
Advent of AI What Will it Take to Drive True Adoption in Clinical Workflows

Nov 14, 2024

Adoption of AI in Healthcare: Adoption in Clinical Workflows

At a panel at LSI USA '24, industry leaders convened to discuss the transformative potential of the adoptio...

Read More next
20 03 24_LSI_DAY_2_(ADAM) 0384

Nov 6, 2024

FDA Breakthrough Device Designation: ROI and Considerations With Shifts in Coverage

At a panel at LSI USA '24, industry experts gathered to share their perspectives on FDA Breakthrough Device...

Read More next
104 LSI USA24 DAY 2 EVE large
Nov 4, 2024

BCI Technologies: Neurotechnology to Address Limitations of the Human Body
next
20 03 24 LSI DAY 2 (ADAM) 0787 large
Nov 3, 2024

International Expansion, Market Development, and Cross-Border Partnerships in the US, EU, and APAC | Insights from LSI USA ‘24
next
LSI Track 4 Day 2 512 large
Nov 1, 2024

Harsh Realities in Building and Financing Medtech Ventures | Insights from LSI USA ‘24
next
LSI Track 4 Day 3 492 large
Oct 23, 2024

Insights from LSI USA ‘24 | Investing for the Long-Haul: Supporting Companies and Aligning Investors Across Stages
next
LSI Track 4 Day 3 534 large
Oct 22, 2024

Insights from LSI USA ‘24: What Does 2024 Hold For the Frozen IPO Market?
next
insights from lsi usa 24 ip friend or foe in building medtech ventures
Oct 18, 2024

Insights from LSI USA ‘24 | IP: Friend or Foe in Building Medtech Ventures?
next
LSI Track 4 Day 3 109 large
Oct 3, 2024

Insights from LSI USA '24: The Verticalization of AI in Medtech and Healthcare
next
blog
Sep 24, 2024

Insights from LSI USA '24: The Agony and Ecstasy of Doing Big Things in Medtech
next
lab_to_market
Sep 11, 2024

Insights From LSI USA ‘24: Bridging the Gap Between Academia and Industry
next
medtech_investors_lsi_usa
Sep 10, 2024

Insights From LSI USA ‘24: Medtech Growth Capital and the New Normal in Late-Stage Financing
next